Podcasts about promis neurosciences

This week Shanti is joined by Dr. James Kupiec, Chief Medical Officer at ProMIS Neurosciences. Shanti and Dr. Kupiec do a deep dive on Biomarkers and discuss recent research coming out of AAIC.

Shanti is joined by Dr. Johanne Kaplan, the Chief Development Officer at ProMIS Neurosciences. The two discuss Dr. Kaplan's career, and the current challenges researchers must tackle as they continue their search for a way to stop Alzheimer's disease. The two also discuss Dr. Kaplan's recent paper on the importance of selectivity in drug development for Alzheimer's.

Dr. Elliot Goldstein, CEO and President of Promis Neurosciences Inc. (OTCQB: ARFXF) joins our podcast to discuss the company's work on discovering and developing antibody therapies that target neurodegenerative diseases.

Today Alzheimer's Speaks Radio  Host, Lori La Bey is going to talk with Dr Elliot Goldstein, with ProMIS Neurosciences about a highly awaited Phase 3 trial and the challenges in Alzheimer's drug development. Further Infomration on ProMIS Neurosciences Website:  www.promisneurosciences.com Additional Resources: https://alzheimersnewstoday.com/2018/01/11/study-shows-promis-alzheimers-therapy-attacks-only-harmful-protein-in-brain/ http://www.bioworld.com/report/BWIS03052018PromisNeurosciences.pdf For Additional Resources fromAlzheimer's Speaks

On this week’s Tech Nation Health, Moira speaks with … Dr. Seth Lederman from Tonix Pharmaceuticals about military-related PTSD. Their drug has been fast-tracked by the FDA. Then on Tech Nation Health, Chief Correspondent Daniel Kraft with Jordan Amadio about the emergent technology in the field of neurosurgery, and Dr. Elliot Goldstein from ProMIS Neurosciences the particular kind of plaque that brings about Alzheimer’s.